147 related articles for article (PubMed ID: 10826900)
21. Expression of CD28 and CD38 by CD8+ T lymphocytes in HIV-1 infection correlates with markers of disease severity and changes towards normalization under treatment. The Swiss HIV Cohort Study.
Bürgisser P; Hammann C; Kaufmann D; Battegay M; Rutschmann OT
Clin Exp Immunol; 1999 Mar; 115(3):458-63. PubMed ID: 10193418
[TBL] [Abstract][Full Text] [Related]
22. Naïve and memory CD4+ T cells and T cell activation markers in HIV-1 infected children on HAART.
Resino S; Navarro J; Bellón JM; Gurbindo D; León JA; Muñoz-Fernández MA
Clin Exp Immunol; 2001 Aug; 125(2):266-73. PubMed ID: 11529919
[TBL] [Abstract][Full Text] [Related]
23. Switch to efavirenz in a protease inhibitor-containing regimen.
Knechten H; Stürner KH; Höhn C; Braun P
HIV Clin Trials; 2001; 2(3):200-4. PubMed ID: 11590528
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of low-dose subcutaneous interleukin-2 to treat advanced human immunodeficiency virus type 1 in persons with Arnó A; Ruiz L; Juan M; Jou A; Balagué M; Zayat MK; Marfil S; Martínez-Picado J; Martínez MA; Romeu J; Pujol-Borrell R; Lane C; Clotet B
J Infect Dis; 1999 Jul; 180(1):56-60. PubMed ID: 10353861
[TBL] [Abstract][Full Text] [Related]
25. Changes in viral expression and cytokine profile induced by a polyantigenic immunomodulator in HIV-infected peripheral blood mononuclear cells.
Ríos Z; Ríos EO; Garcia MI; De Leon C; Guzman LM; Rodriguez W; Romero D; Hunter R
Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S93-101. PubMed ID: 8574153
[TBL] [Abstract][Full Text] [Related]
26. Three-color cytofluorometric analysis of CD8 cell subsets in HIV-1 infection.
Prince HE; Jensen ER
J Acquir Immune Defic Syndr (1988); 1991; 4(12):1227-32. PubMed ID: 1719188
[TBL] [Abstract][Full Text] [Related]
27. CD8+ T-lymphocyte activation in HIV-1 disease reflects an aspect of pathogenesis distinct from viral burden and immunodeficiency.
Liu Z; Cumberland WG; Hultin LE; Kaplan AH; Detels R; Giorgi JV
J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Aug; 18(4):332-40. PubMed ID: 9704938
[TBL] [Abstract][Full Text] [Related]
28. The dominant source of CD4+ and CD8+ T-cell activation in HIV infection is antigenic stimulation.
Cohen Stuart JW; Hazebergh MD; Hamann D; Otto SA; Borleffs JC; Miedema F; Boucher CA; de Boer RJ
J Acquir Immune Defic Syndr; 2000 Nov; 25(3):203-11. PubMed ID: 11115950
[TBL] [Abstract][Full Text] [Related]
29. Expression of CD38 on CD8 T cells predicts maintenance of high viraemia in HAART-treated HIV-1-infected children. Highly active antiretroviral therapy.
Viganó A; Saresella M; Rusconi S; Ferrante P; Clerici M
Lancet; 1998 Dec; 352(9144):1905-6. PubMed ID: 9863793
[No Abstract] [Full Text] [Related]
30. Cell cycling in HIV infection: analysis of in vivo activated lymphocytes.
Mahalingam M; Pozniak A; McManus TJ; Vergani D; Peakman M
Clin Exp Immunol; 1995 Dec; 102(3):481-6. PubMed ID: 8536361
[TBL] [Abstract][Full Text] [Related]
31. Quantitation of CD38 activation antigen expression on CD8+ T cells in HIV-1 infection using CD4 expression on CD4+ T lymphocytes as a biological calibrator.
Hultin LE; Matud JL; Giorgi JV
Cytometry; 1998 Oct; 33(2):123-32. PubMed ID: 9773872
[TBL] [Abstract][Full Text] [Related]
32. CD38+CD8+ T cells as a marker of poor response to therapy in HIV-infected individuals.
Vigano A; Saresella M; Villa ML; Ferrante P; Clerici M
Chem Immunol; 2000; 75():207-17. PubMed ID: 10851786
[No Abstract] [Full Text] [Related]
33. A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable.
Froebel KS; Raab GM; D'Alessandro C; Armitage MP; MacKenzie KM; Struthers M; Whitelaw JM; Yang S
Clin Exp Immunol; 2000 Oct; 122(1):72-8. PubMed ID: 11012621
[TBL] [Abstract][Full Text] [Related]
34. Cd4+ T cells programmed to traffic to lymph nodes account for increases in numbers of cd4+ T cells up to 1 year after the initiation of highly active antiretroviral therapy for human immunodeficiency virus type 1 infection.
Hengel RL; Jones BM; Kennedy MS; Hubbard MR; McDougal JS
J Infect Dis; 2001 Jul; 184(1):93-7. PubMed ID: 11398115
[TBL] [Abstract][Full Text] [Related]
35. During HIV infection, CD4+ CD38+ T-cells are the predominant circulating CD4+ subset whose HLA-DR positivity increases with disease progression and whose V beta repertoire is similar to that of CD4+ CD38- T-cells.
Ramzaoui S; Jouen-Beades F; Gilbert D; Borsa-Lebas F; Michel Y; Humbert G; Tron F
Clin Immunol Immunopathol; 1995 Oct; 77(1):33-41. PubMed ID: 7554481
[TBL] [Abstract][Full Text] [Related]
36. Adrenaline-induced mobilization of T cells in HIV-infected patients.
Søndergaard SR; Cozzi Lepri A; Ullum H; Wiis J; Hermann CK; Laursen SB; Qvist J; Gerstoft J; Skinhøj P; Pedersen BK
Clin Exp Immunol; 2000 Jan; 119(1):115-22. PubMed ID: 10606972
[TBL] [Abstract][Full Text] [Related]
37. Activation and differentiation antigens on T cells of healthy, at-risk, and HIV-infected children.
Plaeger-Marshall S; Hultin P; Bertolli J; O'Rourke S; Kobayashi R; Kobayashi AL; Giorgi JV; Bryson Y; Stiehm ER
J Acquir Immune Defic Syndr (1988); 1993 Sep; 6(9):984-93. PubMed ID: 7688045
[TBL] [Abstract][Full Text] [Related]
38. Limited immune reconstitution at intermediate stages of HIV-1 infection during one year of highly active antiretroviral therapy in antiretroviral-naive versus non-naive adults.
Martín M; Echevarría S; Leyva-Cobián F; Pereda I; López-Hoyos M
Eur J Clin Microbiol Infect Dis; 2001 Dec; 20(12):871-9. PubMed ID: 11837638
[TBL] [Abstract][Full Text] [Related]
39. Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial.
Davey RT; Murphy RL; Graziano FM; Boswell SL; Pavia AT; Cancio M; Nadler JP; Chaitt DG; Dewar RL; Sahner DK; Duliege AM; Capra WB; Leong WP; Giedlin MA; Lane HC; Kahn JO
JAMA; 2000 Jul; 284(2):183-9. PubMed ID: 10889591
[TBL] [Abstract][Full Text] [Related]
40. Expression of activation antigens, HLA-DR and CD38, on CD8 lymphocytes during HIV-1 infection.
Kestens L; Vanham G; Gigase P; Young G; Hannet I; Vanlangendonck F; Hulstaert F; Bach BA
AIDS; 1992 Aug; 6(8):793-7. PubMed ID: 1418775
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
